THEATRE OBSCURA

EXETER PHOENIX BRADNINCH PLACE, GANDY STREET, EXETER  EX4 3LS
  • Dissolved
  • PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
  • Company No. 10532456
  • Last Updated: 27 Jun 2021

Company Profile

THEATRE OBSCURA was incorporated on Monday, December 19, 2016 as a PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) with registered address in EXETER. THEATRE OBSCURA has the status: Dissolved and it's listed in the following category: Other human health activities. This PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption) has been operating for 4 years 4 months and 16 days.

Name THEATRE OBSCURA
Company number 10532456
Company type PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
Incorporation date 19 Dec 2016
Status Dissolved
Industry (SIC 2007)

Address

Registered Address EXETER PHOENIX BRADNINCH PLACE
GANDY STREET
EXETER
EX4 3LS
Country Of Origin

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Mr Robert Guy Newman Nationality: British Dates: Friday, February 1, 2019 - present
voting rights 25 to 50 percent
Amerie Rose Nationality: British Dates: Monday, December 19, 2016 - Friday, February 1, 2019
voting rights 25 to 50 percent
Samantha Hazel Wraith Nationality: British Dates: Monday, December 19, 2016 - Friday, February 1, 2019
voting rights 25 to 50 percent

Accounts and Confirmation

Type of accounts MICRO
End of financial Year 31 December
Next annual accounts due Not available
Latest accounts 31 December 2019
Next confirmation statement due Not available
Last confirmation statement dated 18 December 2020

Mortgages

No mortgages have been registered against THEATRE OBSCURA.

Previous Names

Name Change Date
THEATRE OBSCURA 19 Dec 2016
ENCOUNTER THEATRE & THERAPY 25 Aug 2018